#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Biliary neoplasm B precursor type acute leukaemia Mucous membrane pemphigoid SAPHO syndrome High-grade B-cell lymphoma Lymphangioma Autoimmune hepatitis Depression Neutropenia Marfan's syndrome Ischaemic stroke Measles Uveitis Idiopathic inflammatory myopathy Thyroid cancer metastatic More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Basic Information Noonan syndrome – Life with Disease Marfan’s syndrome – Life with Disease Langerhans cell sarcoma – Life with Disease Glomerulonephritis rapidly progressive – Diagnostics Mucous membrane pemphigoid – Life with Disease Kearns-Sayre syndrome – Treatment Osteosarcoma metastatic – Trials in Disease Friedreich’s ataxia – Trials in Disease Primary mediastinal large B-cell lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SECRETIN SYNTHETIC HUMAN Ferumoxytol Cls12311 12 Grass Pollen Mixture Tadekinig Alfa Ursodeoxycholic Acid Pemigatinib Ganciclovir Lamivudine Aminocaproic Acid Sirexatamab Amniotic Membrane, Human Tralokinumab M1P Dipotassium Salt Amsacrine Xenon Latozinemab Levocetirizine Dihydrochloride Phenylephrine Dobutamine More therapies…

    Learn about Your Condition

    Proteinuria Medication overuse headache Loeys-Dietz syndrome Heparin resistance Pulmonary resection Gouty arthritis Acute myocardial infarction Herpes simplex reactivation Ulcerative keratitis Hypomagnesaemia Stargardt's disease Mantle cell lymphoma recurrent Noonan syndrome Diabetic ketoacidosis Takayasu's arteritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Epstein-Barr virus associated lymphoma

  • Study on Nanatinostat and Valganciclovir for Patients with Epstein-Barr Virus-Positive Relapsed or Refractory Lymphomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus associated lymphoma
    Investigated Drugs:
    • Ganciclovir Sodium
    • Nanatinostat
    • Valganciclovir
    France Germany Italy Spain

  • Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pegfilgrastim
    • Golcadomide
    • Betamethasone Sodium Phosphate
    Austria Bulgaria Czechia Denmark Finland France +11

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!